Nitric Oxide (NO) plays a controversial role in the pathophysiology of sepsis and septic shock. Its vasodilatory effects are well known, but it also has pro- and antiinflammatory properties, assumes crucial importance in antimicrobial host defense, may act as an oxidant as well as an antioxidant, and is said to be a "vital poison" for the immune and inflammatory network. Large amounts of NO and peroxynitrite are responsible for hypotension, vasoplegia, cellular suffocation, apoptosis, lactic acidosis, and ultimately multiorgan failure. Therefore, NO synthase (NOS) inhibitors were developed to reverse the deleterious effects of NO. Studies using these compounds have not met with uniform success however, and a trial using the nonselective NOS inhibitor N(G)-methyl-l-arginine hydrochloride was terminated prematurely because of increased mortality in the treatment arm despite improved shock resolution. Thus, the issue of NOS inhibition in sepsis remains a matter of debate. Several publications have emphasized the differences concerning clinical applicability of data obtained from unresuscitated, hypodynamic rodent models using a pretreatment approach versus resuscitated, hyperdynamic models in high-order species using posttreatment approaches. Therefore, the present review focuses on clinically relevant large-animal studies of endotoxin or living bacteria-induced, hyperdynamic models of sepsis that integrate standard day-to-day care resuscitative measures.

*Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung Universitätsklinikum Ulm Germany; †Aneszteziológiai és Intenzív Terápiás Klinika Semmelweis Egyetem Budapest Hungary; ‡IPS 1 Interní Kliniky Karlova Universita Plzen Czech Republic; and §Princess Alexandra and Wesley Hospitals University of Queensland Brisbane Australia

Zobrazit více v PubMed

Furchgott RF, Zawadadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–6.

Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524–6.

Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987;61:866–79.

Springall DR. Nitric oxide: friend and foe. J Pathol 1995;175:165–6.

Groeneveld AB, Sipkema P. Interaction of oxyradicals, antioxidants, and nitric oxide during sepsis. Crit Care Med 2000;28:2161–2.

Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588–95.

Wink DA, Miranda KM, Espey MG, et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 2001;3:203–13.

Dugas B, Debre P, Moncada S. Nitric oxide, a vital poison inside the immune and inflammatory network. Res Immunol 1995;146:664–70.

Szabó C. Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxnitrite. Biochem Soc Trans 1997;25:919–24.

Kilbourn RG, Szabó C, Traber DL. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 1997;7:235–46.

Vincent JL, Zhang H, Szabó C, Freiser JH. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000;161:1781–5.

Bakker J, Grover R, McLuckie A, et al. Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144–002). Crit Care Med 2004;32:1–12.

Watson D, Grover R, Anzueto A, et al. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144–002). Crit Care Med 2004;32:13–20.

López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21–30.

Dellinger PR, Parillo JE. Modulator therapy of severe sepsis and septic shock: does it work? Crit Care Med 2004;32:278–81.

Traber DL. Expired nitric oxide and shock in higher order species. Crit Care Med 1999;27:255–6.

Reade MC, Young JD. Of mice and men (and rats): implications of species and stimulus differences for the interpretation of studies of nitric oxide in sepsis. Br J Anaesth 2003;90:115–8.

Enkhbaatar P, Traber D. Role of neuronal nitric oxide synthase in cardiopulmonary lesions of sepsis. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine 2004. Berlin, Germany: Springer, 2004:85–92.

Boveris A, Alvarez S, Navarro A. The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med 2002;33:1186–93.

Cohen RI, Hassell AM, Ye X, et al. Lipopolysaccharide down-regulates inducible nitric oxide synthase expression in swine heart in vivo. Biochem Biophys Res Commun 2003;307:451–8.

Enkhbaatar P, Traber DL. Pathophysiology of acute lung injury in combined burn and smoke inhalational injury. Clin Sci (Lond) 2004;107:137–43.

Esch T, Stefano GB, Fricchione GL, Benson H. Stress-related diseases: a potential role for nitric oxide. Med Sci Monit 2002;8:RA103–18.

Burney S, Caulfield JL, Niles JC, et al. The chemistry of DNA damage from nitric oxide and peroxynitrate. Mutat Res 1999;424:37–49.

Inoue M, Sato EF, Park AM, et al. Cross-talk between NO and oxyradicals, a supersystem that regulates energy metabolism and survival of animals. Free Radic Res 2001;33:757–70.

Vallance P, Patton S, Bhagat K, et al. Direct measurement of nitric oxide in human beings. Lancet 1995;346:153–4.

Nüssler AK, Brückner UB, Vogt J, Radermacher P. Measuring end products of nitric oxide in vivo. Methods Enzymol 2002;359:75–83.

Kleinbongard P, Dejam A, Lauer T, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003;35:790–6.

Mehta S, Javeshghani, Datta P, et al. Porcine endotoxemic shock is associated with increased expired nitric oxide. Crit Care Med 1999;27:385–93.

Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219–23.

Šantak B, Radermacher P, Iber T, et al. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion. Br J Pharmacol 1997;122:1605–10.

Bruins MJ, Lamers WH, Meijer AJ, et al. In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxemia. Br J Pharmacol 2002;137:1225–36.

Gomez-Jimenez J, Salgado A, Mourelle M, et al. L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995;23:253–8.

Schedin U, Röken BO, Nyman G, et al. Endogenous nitric oxide in the airways of different animal species. Acta Anaesthesiol Scand 1997;41:1133–41.

Mehta S, Magder S, Levy RD. The effects of changes in ventilation and cardiac output on expired nitric oxide. Chest 1997;111:1045–9.

Gerlach M, Gerlach H. Exhaled nitric oxide. Respir Care 1999;44:349–57.

Chu A, Chambers DE, Lin CC, et al. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 1991;87:1964–8.

Szabó C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxic shock. Br J Pharmacol 1993;108:786–92.

Datta P, Magder S. Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia. Am J Respir Crit Care Med 1999;160:1987–93.

Javeshghani D, Magder S. Regional changes in constitutive nitric oxide synthase and the hemodynamic consequences of its inhibition in lipopolysaccharide-treated pigs. Shock 2001;16:232–8.

Belcher E, Mitchell J, Evans T. Myocardial dysfunction in sepsis: no role for NO? Heart 2002;87:507–9.

Cotton JM, Kearney MT, Shah AM. Nitric oxide and myocardial function in heart failure: friend or foe? Heart 2002;88:564–6.

Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002;8:376–88.

Ishihara S, Ward JA, Tasaki O, et al. Inhaled nitric oxide prevents left ventricular impairment during endotoxemia. J Appl Physiol 1998;85:2018–24.

Kumar A, Brar R, Wang P, et al. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999;276:R265–74.

Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation 1994;89:2070–8.

Soejima K, Schmalsteig FC, Traber LD, et al. Role of nitric oxide in myocardial dysfunction after combined burn and smoke inhalation injury. Burns 2001;27:809–15.

Klabunde RE, Ritger RC. NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 1991;178:1135–40.

Cobb JP, Natanson C, Hoffman WD, et al. N ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992;176:1175–82.

Träger K, Radermacher P, Rieger KM, et al. Norepinephrine and Nω-monomethyl-L-arginine in porcine septic shock: effects on hepatic O2 exhcange and energy balance. Am J Respir Crit Care Med 1999;159:1758–65.

Träger K, Radermacher P, Rieger KM, et al. Norepinephrine and NG-monomethyl-L-arginine in hyperdynamic septic shock in pigs: effects on intestinal oxygen exchange and energy balance. Crit Care Med 2000;28:2007–14.

Cohen RI, Shapir Y, Davis A, et al. Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine. Crit Care Med 2000;28:3257–67.

Cohen RI, Chen L, Scharf SM. The effects of high dose NG-nitro-L-arginine-methyl ester on myocardial blood flow and left ventricular function in dogs. J Crit Care 1996;11:206–13.

Cohen RI, Huberfeld S, Genovese J, et al. A comparison between the acute effects of nitric oxide synthase inhibition and fluid resuscitation on myocardial dysfunction and metabolism in endotoxemic dogs. J Crit Care 1996;11:27–36.

Cohen RI, Shapir Y, Chen L, Scharf SM. Right ventricular overload causes the decrease in cardiac output after nitric oxide synthase inhibition in endotoxemia. Crit Care Med 1998;26:738–47.

Booke M, Hinder F, McGuire R, et al. Noradrenaline and Nω-monomethyl-L-arginine (L-NMMA): effects on hemodynamics and regional blood flow in healthy and septic sheep. Clin Sci (Lond) 2000;98:193–200.

Matejovic M, Radermacher P, Tugtekin I, et al. Effects of selective iNOS inhibition on gut and liver O2-exchange and energy metabolism during hyperdynamic porcine endotoxemia. Shock 2001;16:203–10.

Pittner A, Nalos M, Asfer P, et al. Mechanism of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensive Care Med 2003;29:312–6.

Matejovic M, Krouzecky A, Martinkova V, et al. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004;21:458–65.

Koizumi T, Ogasawara H, Yamamato H, et al. Effect of ONO1714, a specific inducible nitric oxide synthase inhibitor, on lung lymph filtration and gas exchange during endotoxemia in unanesthetized sheep. Anesthesiology 2004;101:59–65.

Enkhbaatar P, Murakami K, Shimoda K, et al. Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury. Am J Physiol Heart Circ Physiol 2003;285:H2430–6.

Levy RJ, Deutschmann CS. Evaluating myocardial depression in sepsis. Shock 2004;22:1–10.

Hinder F, Stubbe HD, van Aken H, et al. Role of nitric oxide in sepsis-associated pulmonary edema. Am J Respir Crit Care Med 1999;159:252–7.

Enkhbaatar P, Murakami K, Shimoda K, et al. The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 2003;167:1021–6.

Enkhbaatar P, Murakami K, Shimoda K, et al. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am J Physiol Regul Integr Comp Physiol 2003;285:R366–72.

Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399–405.

Benzing A, Bräutigam P, Geiger K, et al. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 1995;83:1153–61.

Benzing A, Geiger K. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury. Acta Anaesthesiol Scand 1994;38:640–5.

Sokol J, Jacobs SE, Bohn D. Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: a meta-analysis. Anesth Analg 2003;97:989–98.

Fischer SR, Deyo DJ, Bone HG, et al. Nitric oxide synthase inhibition restores hypoxic pulmonary vasoconstriction in sepsis. Am J Respir Crit Care Med 1997;156:833–9.

Fischer SR, Bone HG, Powell WC, et al. Pyridoxalated hemoglobin polyoxyethylene conjugate does not restore hypoxic pulmonary vasoconstriction in ovine sepsis. Crit Care Med 1997;25:1551–9.

Soejima K, Traber LD, Schmalstieg FC, et al. Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am J Respir Crit Care Med 2001;163:745–52.

Hinder F, Booke M, Traber LD, et al. Nitric oxide and endothelial permeability. Am J Physiol 1997;83:1941–6.

Ogasawara H, Koizumi T, Yamamoto H, Kubo K. Effects of a selective nitric oxide synthase inhibitor on endotoxin-induced alteration in hypoxic pulmonary vasoconstriction in sheep. J Cardiovasc Pharmacol 2003;42:521–6.

Hassoun HT, Kone BC, Mercer DW, et al. Post-injury multiple organ failure: the role of the gut. Shock 2001;15:1–10.

Chavez AM, Menconi MJ, Hodin RA, Fink MP. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999;27:2246–51.

Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997;113:1246–57.

Whittle BJ. Nitric oxide: a mediator of inflammation or mucosal defence. Eur J Gastroenterol Hepatol 1997;9:1026–32.

Han X, Fink MP, Yang R, Delude RL. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 2004;21:261–70.

King CJ, Tytgat S, Delude RL, Fink MP. Ileal mucosal oxygen consumption is decreased in endotoxemic rats but is restored toward normal by treatment with aminoguanidine. Crit Care Med 1999;27:2518–24.

Snygg J, Casselbrant A, Pettersson A, et al. Tonometric assessment of jejunal mucosal nitric oxide formation in anaesthetized pigs. Acta Physiol Scand 2000;169:39–45.

Snygg J, Fändriks L, Bengtsson J, et al. Jejunal luminal nitric oxide during severe hypovolemia and sepsis in anesthetized pigs. Intensive Care Med 2001;27:1807–13.

Malmstrom RE, Bjorne H, Oldner A, et al. Intestinal nitric oxide in the normal and endotoxemic pig. Shock 2002;18:456–60.

Pastor CM, Hadengue A, Nussler AK. Minor involvement of nitric oxide during chronic endotoxemia in anesthetized pigs. Am J Physiol Gastrointest Liver Physiol 2000;278:G416–24.

Spronk PE, Kanoore-Edul VS, Ince C. Microcirculatory and mitochondrial distress syndrome (MMDS): a new look at sepsis. In: Pinsky MR, Payen D, eds. Functional hemodynamic monitoring (update in intensive care and emergency medicine). Berlin, Germany: Springer, 2004:47–67.

Sætre T, Hovig T, Røger M, et al. Hepatocellular damage in porcine endotoxemia: beneficial effects of selective versus non-selective nitric oxide synthase inhibition. Scand J Clin Lab Invest 2001;61:503–12.

Mitaka C, Hirata Y, Yokoyama K, et al. A selective inhibitor for inducible nitric oxide synthase improves hypotension and lactic acidosis in canine endotoxic shock. Crit Care Med 2001;29:2156–61.

Sætre T, Höiby EA, Aspelin T, et al. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit Care Med 2000;28:2697–706.

Li J, Billiar TR. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999;276:G1069–73.

Javesghani D, Hussain SN, Scheidel J, et al. Superoxide production in the vasculature of lipopolysaccharide-treated rats and pigs. Shock 2003;19:486–93.

Schrier RW, Wang W. Acute renal failure in sepsis. N Engl J Med 2004;345:588–95.

Cohen RI, Hassell AM, Marzouk K, et al. Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 2001;164:1890–5.

Booke M, Westphal M, Hinder F, et al. Cerebral blood flow is not altered in sheep with Pseudomonas aeruginosa sepsis treated with norepinephrine or nitric oxide synthase inhibition. Anesth Analg 2003;96:1122–8.

Lingnau W, McGuire R, Dehring DJ, et al. Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremia. Am J Physiol 1996;270:R207–16.

Sharshar T, Annane D, de la Grandmaison GF, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003;362:1799–805.

Sharshar T, Annane D, de la Grandmaison GF, et al. The neuropathology of septic shock. Brain Pathol 2004;14:21–33.

Lanone S, Mebazaa A, Heymes C, et al. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med 2000;162:2308–15.

Boulos M, Astiz ME, Barua RS, Osman M. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med 2003;31:353–8.

Vieira H, Kroemer G. Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life 2003;55:613–6.

Carreras MC, Franco MC, Peralta JG, Poderoso JJ. Nitric oxide, complex I, and the modulation of mitochondrial reactive oxygen species in biology and disease. Mol Aspects Med 2004;25:125–39.

Rudkowski JC, Barreiro E, Harfouche R, et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol 2004;286:L793–800.

Vallance BA, Deng W, De Grado M, et al. Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice. Infect Immun 2002;70:6424–35.

Meng QH, Springall DR, Bishop AE, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998;184:323–31.

Hickman-Davis JM, Fang FC, Nathan C, et al. Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen infections. Am J Physiol Lung Cell Mol Physiol 2001;281:L517–23.

Hauser B, Radermacher P, Thiemermann C, Matejovic M. Nitric oxide, bacteria and host defense in sepsis: who needs what? Shock 2004;22:588–90.

Crowley JP, Metzger J, Gray A, et al. Infusion of stroma-free cross-linked hemoglobin during acute gram-negative bacteremia. Circ Shock 1993;41:144–9.

Crouser ED, Julian MW, Weinstein DM, et al. Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. Am J Respir Crit Care Med 2000;161:1705–12.

Lobo SM, De Backer D, Sun Q, et al. Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemia. J Appl Physiol 2003;95:2047–54.

Kozlov AV, Sobhian B, Duvigneau JC, et al. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion. J Lab Clin Med 2002;140:303–11.

Luiking Y, Poeze M, Dejong CH, et al. Sepsis: an arginine deficiency state? Crit Care Med 2004;32:2135–45.

Domenico R. Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies. Curr Pharm Des 2004;10:1667–76.

Year in review 2006: Critical Care--Multiple organ failure, sepsis, and shock